Medicinova (MNOV) Non-Current Deffered Revenue (2011 - 2021)

Medicinova (MNOV) has 11 years of Non-Current Deffered Revenue data on file, last reported at $1.7 million in Q2 2021.

• On a quarterly basis, Non-Current Deffered Revenue changed 0.0% year-over-year to $1.7 million in Q2 2021; TTM through Jun 2021 was $1.7 million, a 0.0% change from a year earlier, with the FY2020 full-year figure at $1.7 million, changed 0.0% from the prior year.
• Non-Current Deffered Revenue for Q2 2021 stood at $1.7 million, roughly flat from $1.7 million in the prior quarter.
• Over the last five years, Non-Current Deffered Revenue for MNOV reached as high as $1.7 million in Q1 2017 and fell as low as $253.0 in Q4 2017.
• Historically, Non-Current Deffered Revenue has averaged $1.5 million across 5 years, with a median of $1.7 million in 2017.
• On a YoY basis, Non-Current Deffered Revenue climbed as much as 669529.64% in 2018 and fell as far as 98.6% in 2018.
• Year by year, Non-Current Deffered Revenue stood at $253.0 in 2017, then surged by 669529.64% to $1.7 million in 2018, then changed by 0.0% to $1.7 million in 2019, then changed by 0.0% to $1.7 million in 2020, then changed by 0.0% to $1.7 million in 2021.
• Per Business Quant data, the three most recent Non-Current Deffered Revenue figures were $1.7 million in Q2 2021, $1.7 million in Q1 2021, and $1.7 million in Q4 2020.